Strategic Asset Management, LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1888541 ROCHESTER, MN

Position in ZVRA

as of Sep 30, 2022 · filed Nov 1, 2022 Compact

Position Value

$260,476

+$81,688 QoQ

Shares Held

41,743

+4.1% QoQ

Ownership

0.070%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Sep 30, 2022

Strategic Asset Management, LLC holds $279,587 across 5 Biotechnology names. ZVRA ranks #1 (93.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZVRA	Zevra Therapeutics, Inc. This page	41,743	$260,476
2	VXRT	Vaxart, Inc.	6,000	$13,080
3	ONCY	Oncolytics Biotech Inc	2,500	$3,075
4	MRNA	Moderna, Inc.	25	$2,956
5	CRVO	CervoMed Inc.	40	$0

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2022-09-30	$260,476	41,743	+4.1%	Shares	Sole	2022-11-01
2022-06-30	$178,788	40,087	0.0%	Shares	Sole	2022-07-14
2022-03-31	$201,637	40,087	+16.7%	Shares	Sole	2022-04-20
2021-12-31	$299,171	34,348	-0.0%	Shares	Sole	2022-01-26
2021-09-30	$320,625	34,365	—	Shares	Sole	2021-11-04
No filing history on record for this holder in this stock.